GBPAUD - BULLISH BIAS
GBP - Weak Bullish
1️⃣ According to UK’s Public Health officials, the Pfizer and AstraZeneca vaccines are only 33% effective against the Delta variant after a single shot. However, the effectiveness of both vaccines improves to above 90% after two doses.
2️⃣ Focus are now will be on fresh macro updates on jobs and retail sales - both expected to be GBP supportive.
AUD - Weak Bearish
1️⃣ Investors this week are expected to be cautious ahead of the FOMC meeting and avoid putting money in high-yielding countries.
2️⃣ Recent disappointment in AU business and consumer confidence.
=====
Technical
=====
We are buying the GBPAUD at support + SMA 50 + pivot point on the H1 chart.
=====
Risk to this trade
=====
Any change in sentiment could turn the pair's direction.
1️⃣ According to UK’s Public Health officials, the Pfizer and AstraZeneca vaccines are only 33% effective against the Delta variant after a single shot. However, the effectiveness of both vaccines improves to above 90% after two doses.
2️⃣ Focus are now will be on fresh macro updates on jobs and retail sales - both expected to be GBP supportive.
AUD - Weak Bearish
1️⃣ Investors this week are expected to be cautious ahead of the FOMC meeting and avoid putting money in high-yielding countries.
2️⃣ Recent disappointment in AU business and consumer confidence.
=====
Technical
=====
We are buying the GBPAUD at support + SMA 50 + pivot point on the H1 chart.
=====
Risk to this trade
=====
Any change in sentiment could turn the pair's direction.
Trade active
Trade closed: target reached
✅ TRADE HAS HIT TP+35 PIPS
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.